Yunzhi Essence to Improve the Quality of Life of Patients With Advanced Stage of Cancer
Trial statusRecruiting
Trial phasePhase 2
Trial typeInterventional
Biological sexAll
Age21-89
SponsorChinese University of Hong Kong
About this trial
A randomized, double-blinded, placebo-controlled clinical trial using a Chinese Medicine 'Coriolus Versicolor for improving the quality of life of patients with advanced-stage cancer. Subjects will be randomized into a treatment group or placebo group for 6 months.
Eligibility criteria
Qualifiers
Diagnosed with advanced cancer according to the definition from American Cancer Society;
According to the experience of the doctor, by using Palliative Prognostic Index (score>4), integrated with past cases and professional knowledge judged to have life expectancy not less than six months to two years;
Abbreviated mental test (AMT) score of 6 or above;
Voluntarily participate in this clinical trial and sign the informed consent form (acceptance of close relatives signed informed consent on behalf of the patient);
Disqualifiers
Patients with a history of allergy to traditional Chinese medicine or Yunzhi;
Patients who required nasal feeding or difficulty swallowing;
Patients with comatose/semi-conscious, cognitively impaired with dementia/confusion, physically too ill with extremely poor general condition, or there was a language barrier.
Trial design
Treatments tested in this trial
- Yunzhi Essence
- Placebo
Treatment groups
172 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov